Classifications

• • C—CHEMISTRY; METALLURGY
  • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
  • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
  • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
  • C12N9/10—Transferases (2.)
  • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
  • C12N9/1288—Transferases for other substituted phosphate groups (2.7.8)

Definitions

• This invention relates to the genes and enzymes involved in cell wall synthesis in bacteria.
• PG peptidoglycan
• MraY One enzyme intrinsic to the peptidoglycan biosynthesis is MraY. To date, no MraY sequences have been disclosed for Pseudomonas aeruginosa, an opportunistic pathogen causing infections in patients with burns or neutropenia.
• Polynucleotides and polypeptides of Pseudomonas aeruginosa MraY, an enzyme involved in bacterial cell wall biosynthesis, are provided.
• the recombinant MraY enzyme is catalytically active in the first step of the membrane cycle of peptidoglycan biosynthesis, transferring the N-acetylmuramic acid pentapeptide to a bactoprenol phosphate carrier molecule.
• the enzyme is useful in in vitro assays to screen for antibacterial compounds that target cell wall biosynthesis.
• the invention includes the polynucleotides, proteins encoded by the polynucleotides, and host cells expressing the recombinant enzyme, probes and primers, and the use of these molecules in assays.
• An aspect of this invention is an isolated polynucleotide having a sequence encoding a Pseudomonas aeruginosa MraY protein, or a complementary sequence.
• the encoded protein has a sequence corresponding to SEQ ID ⁇ O:2.
• the polynucleotide can be DNA, RNA or a mixture of both, and can be single or double stranded.
• the polynucleotide has a sequence shown in SEQ ID NO:l.
• An aspect of this invention is a probe having a sequence of at least about 25 contiguous nucleotides that is specific for a naturally occurring polynucleotide encoding a Pseudomonas aeruginosa MraY protein. Probes in accordance with this description are useful for the specific detection of the presence of a polynucleotide encoding a Pseudomonas aeruginosa MraY protein. In preferred embodiments, the probes of this aspect can have additional components including, but not limited to, compounds, isotopes, proteins or sequences for ready detection.
• An aspect of this invention is a primer having a sequence of at least about 25 contiguous nucleotides that is specific for a naturally occurring polynucleotide encoding a Pseudomonas aeruginosa MraY protein. Primers in accordance with this description are useful in nucleic acid amplification-based assays for the specific detection of the presence of a polynucleotide encoding a Pseudomonas aeruginosa MraY protein. In preferred embodiments, the primers of this aspect can have additional components including, but not limited to, compounds, isotopes, proteins or sequences for ready detection.
• An aspect of this invention is an expression vector including a polynucleotide encoding a Pseudomonas aeruginosa MraY protein, or a complementary sequence, and regulatory regions.
• the encoded protein has a sequence corresponding to SEQ ID NO:2.
• the vector can have any of a variety of regulatory regions known and used in the art as appropriate for the types of host cells the vector can be used in.
• the vector has regulatory regions appropriate for the expression of the encoded protein in gram-negative prokaryotic host cells.
• the vector has regulatory regions appropriate for expression of the encoded protein in gram-positive host cells, yeasts, cyanobacteria or actinomycetes.
• the regulatory regions provide for inducible expression while in other preferred embodiments the regulatory regions provide for constitutive expression.
• the expression vector can be derived from a plasmid, phage, virus or a combination thereof.
• An aspect of this invention is a host cell comprising an expression vector including a polynucleotide encoding a Pseudomonas aeruginosa MraY protein, or a complementary sequence, and regulatory regions.
• the encoded protein has a sequence corresponding to SEQ ID NO:2.
• the host cell is a yeast, gram-positive bacterium, cyanobacterium or actinomycete.
• the host cell is a gram-negative bacterium.
• An aspect of this invention is a process for expressing a MraY protein of P. aeruginosa in a host cell.
• a host cell is transformed or transfected with an expression vector including a polynucleotide encoding a Pseudomonas aeruginosa MraY protein, or a complementary sequence.
• the host cell is cultured under conditions conducive to the expression of the encoded MraY protein.
• the expression is inducible or constitutive.
• the encoded protein has a sequence corresponding to SEQ ID NO:2.
• An aspect of this invention is a purified polypeptide having an amino acid sequence of SEQ ID NO:2.
• Cellular extracts comprising a polypeptide having the above amino acid sequence are also included within the instant invention.
• FIG. 1 Nucleotide sequence (SEQ ID NO: 1) and the predicted amino acid sequence (SEQ ID NO:2) of P. aeruginosa MraY.
• the amino acid sequence (SEQ ID NO:2) is presented in a three-letter code below the nucleotide sequence (nucleotides 34 to 1113 of SEQ ID NO: 1).
• This invention provides polynucleotides and polypeptides of a cell wall biosynthesis gene from Pseudomonas aeruginosa, referred to herein as MraY.
• the polynucleotides and polypeptides are used to further provide expression vectors, host cells comprising the vectors, probes and primers, and assays for the presence or expression of MraY.
• Bacterial mraY encodes for phoshpo-N-acetylmuramoyl-pentapeptide translocase, an enzyme responsible for catalyzing the first step of the membrane cycle of peptidoglycan biosynthesis, transfer of the N-acetylmuramic acid pentapeptide to a bactoprenol phosphate carrier molecule.
• the mraY gene was cloned from Pseudomonas aeruginosa. Sequence analysis of the P. aeruginosa mraY gene revealed an open reading frame of 361 amino acids. Nucleic acids encoding MraY from Pseudomonas aeruginosa are useful in the expression and production of the P. aeruginosa MraY protein. The nucleic acids are also useful in providing probes for detecting the presence of P. aeruginosa MraY.
• polynucleotide means a nucleic acid of more than one nucleotide.
• a polynucleotide can be made up of multiple polynucleotide units that are referred to by description of the unit.
• a polynucleotide can comprise within its bounds a polynucleotide(s) having a coding sequence(s), a polynucleotide(s) that is a regulatory region(s) and/or other polynucleotide units commonly used in the art.
• expression vector means a polynucleotide having regulatory regions operably linked to a coding region such that, when in a host cell, the regulatory regions can direct the expression of the coding sequence.
• expression vectors can be used in a variety of host cells and, therefore, the regulatory regions are preferably chosen as appropriate for the particular host cell.
• regulatory region means a polynucleotide that can promote or enhance the initiation or termination of transcription or translation of a coding sequence.
• a regulatory region includes a sequence that is recognized by the RNA polymerase, ribosome, or associated transcription or translation initiation or termination factors of a host cell. Regulatory regions that direct the initiation of transcription or translation can direct constitutive or inducible expression of a coding sequence.
• purified and isolated are utilized interchangeably to stand for the proposition that the polynucleotide, protein and polypeptide, or respective fragments thereof in question have been removed from the in vivo environment so that they exist in a form or purity not found in nature. This, however, is not mandated of cDNA as understood by one of ordinary skill in the art.
• substantially pure with regard to a polynucleotide means it is obtained purified from cellular components by standard methods at a concentration of at least about 100-fold higher than that found in nature.
• a polynucleotide is considered essentially pure if it is obtained at a concentration of at least about 1000- fold higher than that found in nature.
• Polynucleotides useful in the present invention include those described herein and those that one of skill in the art will be able to derive therefrom following the teachings of this specification.
• An aspect of the present invention is a polynucleotide encoding a MraY protein of Pseudomonas aeruginosa. It is known that there is a substantial amount of redundancy in the various codons which code for specific amino acids. Therefore, this invention is also directed to those DNA sequences that encode RNA comprising alternative codons which code for the eventual translation of the identical amino acid. The present invention, thus, discloses codon redundancy which can result in different DNA molecules encoding an identical protein. For purposes of this specification, a sequence bearing one or more replaced codons will be defined as a degenerate variation.
• a further aspect of the present invention is a cDNA encoding a MraY protein of Pseudomonas aeruginosa.
• a preferred aspect of the present invention is an isolated nucleic acid encoding a MraY protein of Pseudomonas aeruginosa.
• a preferred embodiment is a nucleic acid having the sequence disclosed in FIG. 1, SEQ ED NO: l.
• the isolated nucleic acid molecule of the present invention can include a ribonucleic or deoxyribonucleic acid molecule, which can be single (coding or noncoding strand) or double stranded, as well as synthetic nucleic acid, such as a synthesized, single stranded polynucleotide.
• Noncoding or antisense strands can be useful as modulators of the gene by interacting with RNA encoding the MraY protein.
• Antisense strands are preferably less than full length strands having sequences unique or specific for RNA encoding the polypeptide.
• polynucleotides that hybridize to P.aeruginosa mraY sequences under stringent conditions are also included in the present invention.
• a procedure using conditions of high stringency is as follows: Prehybridization of filters containing DNA is carried out for 2 hr. to overnight at 65°C in buffer composed of 6X SSC, 5X Denhardt's solution, and 100 ⁇ g/ml denatured salmon sperm DNA. Filters are hybridized for 12 to 48 hrs at 65°C in prehybridization mixture containing 100 ⁇ g/ml denatured salmon sperm DNA and 5-20 X 106 cpm of 32p_ ⁇ a beled probe. Washing of filters is done at 37°C for 1 hr in a solution containing 2X SSC, 0.1% SDS. This is followed by a wash in 0.1X SSC, 0.1% SDS at 50°C for 45 min. before autoradiography.
• a preferred aspect of the present invention is a substantially purified form of the MraY protein from Pseudomonas aeruginosa.
• a preferred embodiment is a protein that has the amino acid sequence which is shown in FIG. 1, in SEQ ID NO:2.
• Probes comprising full length or partial sequences of SEQ ID NO: 1 can be used to determine whether a cell or sample contains P. aeruginosa mraY ON A or RNA.
• a preferred probe is a single stranded antisense probe having at least the full length of the coding sequence of MraY. It is also preferred to use probes that have less than the full length sequence, and contain sequences specific for P. aeruginosa mraY ON A or RNA.
• the identification of a sequence(s) for use as a specific probe is well known in the art and involves choosing a sequence(s) that is unique to the target sequence, or is specific thereto.
• probes have at least about 25 nucleotides, more preferably about 30 to 35 nucleotides.
• the longer probes are believed to be more specific for P. aeruginosa mraY gene(s) and RNAs and can be used under more stringent hybridization conditions. Longer probes can be used but can be more difficult to prepare synthetically, or can result in lower yields from synthesis.
• sequences that are useful as probes or primers for P. aeruginosa mraY gene(s) are Primer A (sense) 5 '- TT CAT ATG CTC CTG CTG CTG GCC GAA TAC -3' (SEQ ID NO:3) and Primer B (antisense) 5'- TT GGA TCC TCA ACG CAG CTT CAA GGT G -3' (SEQ ID NO:4). Restriction sites, underlined, for Ndel and BamHI are added to the 5' ends of the primers to allow cloning between the Ndel and BamHI sites of the expression vector pET-1 la. However, one skilled in the art will recognize that these are only a few of the useful probe or primer sequences that can be derived from SEQ ID NO: 1.
• Polynucleotides having sequences that are unique or specific for P. aeruginosa MraY can be used as primers in amplification reaction assays. These assays can be used in tissue typing as described herein. Additionally, amplification reactions employing primers derived from P. aeruginosa MraY sequences can be used to obtain amplified P. aeruginosa mraY ON A using the rnr ⁇ FDNA of the cells as an initial template. Many types of amplification reactions are known in the art and include, without limitation, Polymerase Chain Reaction, Reverse Transcriptase Polymerase Chain Reaction, Strand Displacement Amplification and Self-Sustained Sequence Reaction. Any of these or like reactions can be used with primers derived from SEQ ID NO: 1.
• expression vectors can be used to express recombinant MraY in host cells.
• Expression vectors are defined herein as nucleic acid sequences that include regulatory sequences for the transcription of cloned DNA and the translation of their mRNAs in an appropriate host.
• Such vectors can be used to express a bacterial gene in a variety of hosts such as bacteria, bluegreen algae, plant cells, insect cells and animal cells. Specifically designed vectors allow the shuttling of genes between hosts such as bacteria- yeast or bacteria-animal cells.
• An appropriately constructed expression vector should contain: an origin of replication for autonomous replication in host cells, selectable markers, a limited number of useful restriction enzyme sites, a potential for high copy number, and regulatory sequences.
• Expression vectors can include, but are not limited to, cloning vectors, modified cloning vectors, specifically designed plasmids or viruses.
• bacterial expression vectors can be used to express recombinant MraY in bacterial cells.
• Commercially available bacterial expression vectors which are suitable for recombinant MraY expression include, but are not limited to pQE (Qiagen), pETl la (Novagen), lambda gtll (Invitrogen), and pKK223-3 (Pharmacia).
• mraY DNA in cell-free transcription- translation systems, or mr ⁇ FRNA in cell-free translation systems.
• Cell-free synthesis of MraY can be in batch or continuous formats known in the art.
• MraY chemically, although this method is not preferred.
• a variety of host cells can be employed with expression vectors to synthesize MraY protein. These can include E. coli, Bacillus, and Salmonella. Insect and yeast cells can also be appropriate.
• MraY polypeptides can be recovered.
• MraY protein and polypeptides can be purified from cell lysates and extracts, or from culture medium, by various combinations of, or individual application of methods including ultrafiltration, acid extraction, alcohol precipitation, salt fractionation, ionic exchange chromatography, phosphocellulose chromatography, lecithin chromatography, affinity (e.g., antibody or His-Ni) chromatography, size exclusion chromatography, hydroxylapatite adsorption chromatography and chromatography based on hydrophobic or hydrophillic interactions.
• protein denaturation and refolding steps can be employed.
• High performance liquid chromatography (HPLC) and reversed phase HPLC can also be useful. Dialysis can be used to adjust the final buffer composition.
• Genomic DNA from P. aeruginosa was prepared from 100 ml late stationary phase culture in Brain Heart Infusion broth (DIFCO, Detroit, MI). Cells were washed with 0.2 M sodium acetate, suspended in 10 ml of TEG (100 mM Tris, pH 7, containing 10 mM EDTA and 25% glucose) and lysed by incubation with 200 ⁇ g of N-acetylmuramidase (SIGMA) for lh at 37°C. Chromosomal DNA was purified from the cell lysate using a QIAGEN (Santa Clarita, CA) genomic DNA preparation kit following the manufacturers' protocol.
• the cell lysate was treated with protease K at 50°C for 45 min, loaded onto an equilibrated QIAGEN genomic tip, and entered into the resin by centrifugation at 3000 rpm for 2 min. Following washing the genomic tip, the genomic DNA was eluted in distilled water and kept at 4°C. Approximately 50 ng genomic DNA was used as a template in PCR reactions to clone mraY. Two oligonucleotide primers (GIBCO/BRL, Bethesda, MD) complementary to sequences at the 5' and the 3' ends of P.
• aeruginosa mraY were used to clone this gene using KLENTAQ ADVANTAGETM polymerase (CLONTECH, Palo Alto, CA).
• the primer nucleotide sequences were as follows: 5'- TT CAT ATG CTC CTG CTG CTG GCC GAA TAC -3' (SEQ ID NO:3) and 5'- TT GGA TCC TCA ACG CAG CTT CAA GGT G -3' (SEQ ID NO:4).
• aeruginosa mraY was verified by nucleotide sequence, digested with Ndel and BamHI, and cloned between the Ndel and BamHI sites of pET-1 la, creating plasmid pPaeMraY. This plasmid was used for expression of the mraY gene in E. coli.
• the mraY was cloned into the expression vector pET-1 la (Novagen) as described above to create plasmid pPaeMraY.
• the pET-1 la vector allows expression of authentic, non-fusion, proteins.
• the pET (Plasmids for Expression by T7 RNA polymerase) plasmids are derived from pBR322 and designed for protein over- production in E. coli.
• the vector pET-1 la contains the ampicillin resistance gene, and ColEl origin of replication, in addition to T7 phage promoter and terminator.
• the T7 promoter is recognized by the phage T7 RNA polymerase but not by the E. coli RNA polymerase.
• a host E coli strain such as BL21(DE3)pLysS is engineered to contain integrated copies of T7 RNA polymerase under the control of lacUV5 that is inducible by IPTG. Production of a recombinant protein in the E. coli strain BL21(DE3)pLysS occurs after expression of T7RNA polymerase is induced.
• NOVAGEN M9ZB medium
• MraY (translocase I) assay was performed using the butanol extraction method described by Brandish and coworkers (Brandish et al, 1996 J. Biol. Chem. 271(13):7609-7614). The assay was performed at room temperature with assay components held at concentrations of: 100 mM TRIS, pH 7.5; 30 mM MgCl2;

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Health & Medical Sciences (AREA)
• Genetics & Genomics (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Zoology (AREA)
• Wood Science & Technology (AREA)
• Molecular Biology (AREA)
• Microbiology (AREA)
• Biotechnology (AREA)
• Biomedical Technology (AREA)
• Biochemistry (AREA)
• General Engineering & Computer Science (AREA)
• General Health & Medical Sciences (AREA)
• Medicinal Chemistry (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Enzymes And Modification Thereof (AREA)

Applications Claiming Priority (3)

Publications (2)

Family

ID=22564366

Family Applications (1)

Country Status (3)

Cited By (1)

Families Citing this family (1)

Citations (1)

Family Cites Families (3)

• 2000
  • 2000-09-29 CA CA002386235A patent/CA2386235A1/en not_active Abandoned
  • 2000-09-29 WO PCT/US2000/027056 patent/WO2001025251A1/en not_active Application Discontinuation
  • 2000-09-29 EP EP00968545A patent/EP1222197A4/de not_active Withdrawn

Patent Citations (1)

Non-Patent Citations (4)

Also Published As

Similar Documents

Legal Events